BC Gov expanding coverage for HIV pre-exposure throughout the province

The Health Ministry is celebrating what they are calling six-months of success in preventing new HIV infections throughout BC.

At the start of this year, the government expanded coverage for HIV pre-exposure prophylaxis(pep), which has been prescribed to over two-thousand residents.

In celebration of this, the province and the BC Centre for Excellence in HIV/AIDS is continuing to expand the coverage to reduce the number of new HIV infections.

According to the BC Centre for Disease Control, the rate of HIV infections dropped in 2017, with 190 cases reported compared to the over 250 in 2016.

Northern Health recorded 13 cases in 2016.

When it comes to making PEP available outside of the Lower Mainland, Health Minister Adrian Dix says they are holding a conference this week to address where and how they should expand the coverage in the north.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search